Click for best price
Vaginal Antifungal Market Size, Share 2024
The global Vaginal Antifungal market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Fluconazole Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Vaginal Antifungal include ANI Pharmaceuticals, Lupin, Unique Pharmaceuticals, Pfizer, SCYNEXIS, Bausch Health Companies, Hikma Pharmaceuticals, Pacgen Life Science Corporation and Astellas Pharma, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Vaginal Antifungal, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaginal Antifungal. This report contains market size and forecasts of Vaginal Antifungal in global, including the following market information:
Global Vaginal Antifungal Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Vaginal Antifungal companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vaginal Antifungal Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Vaginal Antifungal Market Segment Percentages, by Type, 2023 (%)
Fluconazole
Clotrimazole
Ketoconazole
Others
Global Vaginal Antifungal Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Vaginal Antifungal Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Pharmacy
Global Vaginal Antifungal Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Vaginal Antifungal Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vaginal Antifungal revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Vaginal Antifungal revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
ANI Pharmaceuticals
Lupin
Unique Pharmaceuticals
Pfizer
SCYNEXIS
Bausch Health Companies
Hikma Pharmaceuticals
Pacgen Life Science Corporation
Astellas Pharma
Mycovia Pharmaceuticals
PEPTONIC Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vaginal Antifungal, market overview.
Chapter 2: Global Vaginal Antifungal market size in revenue.
Chapter 3: Detailed analysis of Vaginal Antifungal company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vaginal Antifungal in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Vaginal Antifungal Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Vaginal Antifungal Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vaginal Antifungal Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vaginal Antifungal Overall Market Size
2.1 Global Vaginal Antifungal Market Size: 2023 VS 2030
2.2 Global Vaginal Antifungal Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Vaginal Antifungal Players in Global Market
3.2 Top Global Vaginal Antifungal Companies Ranked by Revenue
3.3 Global Vaginal Antifungal Revenue by Companies
3.4 Top 3 and Top 5 Vaginal Antifungal Companies in Global Market, by Revenue in 2023
3.5 Global Companies Vaginal Antifungal Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vaginal Antifungal Players in Global Market
3.6.1 List of Global Tier 1 Vaginal Antifungal Companies
3.6.2 List of Global Tier 2 and Tier 3 Vaginal Antifungal Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Vaginal Antifungal Market Size Markets, 2023 & 2030
4.1.2 Fluconazole
4.1.3 Clotrimazole
4.1.4 Ketoconazole
4.1.5 Others
4.2 By Type - Global Vaginal Antifungal Revenue & Forecasts
4.2.1 By Type - Global Vaginal Antifungal Revenue, 2019-2024
4.2.2 By Type - Global Vaginal Antifungal Revenue, 2025-2030
4.2.3 By Type - Global Vaginal Antifungal Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Vaginal Antifungal Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Pharmacy
5.2 By Application - Global Vaginal Antifungal Revenue & Forecasts
5.2.1 By Application - Global Vaginal Antifungal Revenue, 2019-2024
5.2.2 By Application - Global Vaginal Antifungal Revenue, 2025-2030
5.2.3 By Application - Global Vaginal Antifungal Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Vaginal Antifungal Market Size, 2023 & 2030
6.2 By Region - Global Vaginal Antifungal Revenue & Forecasts
6.2.1 By Region - Global Vaginal Antifungal Revenue, 2019-2024
6.2.2 By Region - Global Vaginal Antifungal Revenue, 2025-2030
6.2.3 By Region - Global Vaginal Antifungal Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Vaginal Antifungal Revenue, 2019-2030
6.3.2 US Vaginal Antifungal Market Size, 2019-2030
6.3.3 Canada Vaginal Antifungal Market Size, 2019-2030
6.3.4 Mexico Vaginal Antifungal Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Vaginal Antifungal Revenue, 2019-2030
6.4.2 Germany Vaginal Antifungal Market Size, 2019-2030
6.4.3 France Vaginal Antifungal Market Size, 2019-2030
6.4.4 U.K. Vaginal Antifungal Market Size, 2019-2030
6.4.5 Italy Vaginal Antifungal Market Size, 2019-2030
6.4.6 Russia Vaginal Antifungal Market Size, 2019-2030
6.4.7 Nordic Countries Vaginal Antifungal Market Size, 2019-2030
6.4.8 Benelux Vaginal Antifungal Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Vaginal Antifungal Revenue, 2019-2030
6.5.2 China Vaginal Antifungal Market Size, 2019-2030
6.5.3 Japan Vaginal Antifungal Market Size, 2019-2030
6.5.4 South Korea Vaginal Antifungal Market Size, 2019-2030
6.5.5 Southeast Asia Vaginal Antifungal Market Size, 2019-2030
6.5.6 India Vaginal Antifungal Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Vaginal Antifungal Revenue, 2019-2030
6.6.2 Brazil Vaginal Antifungal Market Size, 2019-2030
6.6.3 Argentina Vaginal Antifungal Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Vaginal Antifungal Revenue, 2019-2030
6.7.2 Turkey Vaginal Antifungal Market Size, 2019-2030
6.7.3 Israel Vaginal Antifungal Market Size, 2019-2030
6.7.4 Saudi Arabia Vaginal Antifungal Market Size, 2019-2030
6.7.5 UAE Vaginal Antifungal Market Size, 2019-2030
7 Vaginal Antifungal Companies Profiles
7.1 ANI Pharmaceuticals
7.1.1 ANI Pharmaceuticals Company Summary
7.1.2 ANI Pharmaceuticals Business Overview
7.1.3 ANI Pharmaceuticals Vaginal Antifungal Major Product Offerings
7.1.4 ANI Pharmaceuticals Vaginal Antifungal Revenue in Global Market (2019-2024)
7.1.5 ANI Pharmaceuticals Key News & Latest Developments
7.2 Lupin
7.2.1 Lupin Company Summary
7.2.2 Lupin Business Overview
7.2.3 Lupin Vaginal Antifungal Major Product Offerings
7.2.4 Lupin Vaginal Antifungal Revenue in Global Market (2019-2024)
7.2.5 Lupin Key News & Latest Developments
7.3 Unique Pharmaceuticals
7.3.1 Unique Pharmaceuticals Company Summary
7.3.2 Unique Pharmaceuticals Business Overview
7.3.3 Unique Pharmaceuticals Vaginal Antifungal Major Product Offerings
7.3.4 Unique Pharmaceuticals Vaginal Antifungal Revenue in Global Market (2019-2024)
7.3.5 Unique Pharmaceuticals Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Vaginal Antifungal Major Product Offerings
7.4.4 Pfizer Vaginal Antifungal Revenue in Global Market (2019-2024)
7.4.5 Pfizer Key News & Latest Developments
7.5 SCYNEXIS
7.5.1 SCYNEXIS Company Summary
7.5.2 SCYNEXIS Business Overview
7.5.3 SCYNEXIS Vaginal Antifungal Major Product Offerings
7.5.4 SCYNEXIS Vaginal Antifungal Revenue in Global Market (2019-2024)
7.5.5 SCYNEXIS Key News & Latest Developments
7.6 Bausch Health Companies
7.6.1 Bausch Health Companies Company Summary
7.6.2 Bausch Health Companies Business Overview
7.6.3 Bausch Health Companies Vaginal Antifungal Major Product Offerings
7.6.4 Bausch Health Companies Vaginal Antifungal Revenue in Global Market (2019-2024)
7.6.5 Bausch Health Companies Key News & Latest Developments
7.7 Hikma Pharmaceuticals
7.7.1 Hikma Pharmaceuticals Company Summary
7.7.2 Hikma Pharmaceuticals Business Overview
7.7.3 Hikma Pharmaceuticals Vaginal Antifungal Major Product Offerings
7.7.4 Hikma Pharmaceuticals Vaginal Antifungal Revenue in Global Market (2019-2024)
7.7.5 Hikma Pharmaceuticals Key News & Latest Developments
7.8 Pacgen Life Science Corporation
7.8.1 Pacgen Life Science Corporation Company Summary
7.8.2 Pacgen Life Science Corporation Business Overview
7.8.3 Pacgen Life Science Corporation Vaginal Antifungal Major Product Offerings
7.8.4 Pacgen Life Science Corporation Vaginal Antifungal Revenue in Global Market (2019-2024)
7.8.5 Pacgen Life Science Corporation Key News & Latest Developments
7.9 Astellas Pharma
7.9.1 Astellas Pharma Company Summary
7.9.2 Astellas Pharma Business Overview
7.9.3 Astellas Pharma Vaginal Antifungal Major Product Offerings
7.9.4 Astellas Pharma Vaginal Antifungal Revenue in Global Market (2019-2024)
7.9.5 Astellas Pharma Key News & Latest Developments
7.10 Mycovia Pharmaceuticals
7.10.1 Mycovia Pharmaceuticals Company Summary
7.10.2 Mycovia Pharmaceuticals Business Overview
7.10.3 Mycovia Pharmaceuticals Vaginal Antifungal Major Product Offerings
7.10.4 Mycovia Pharmaceuticals Vaginal Antifungal Revenue in Global Market (2019-2024)
7.10.5 Mycovia Pharmaceuticals Key News & Latest Developments
7.11 PEPTONIC Medical
7.11.1 PEPTONIC Medical Company Summary
7.11.2 PEPTONIC Medical Business Overview
7.11.3 PEPTONIC Medical Vaginal Antifungal Major Product Offerings
7.11.4 PEPTONIC Medical Vaginal Antifungal Revenue in Global Market (2019-2024)
7.11.5 PEPTONIC Medical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Vaginal Antifungal Market Opportunities & Trends in Global Market
Table 2. Vaginal Antifungal Market Drivers in Global Market
Table 3. Vaginal Antifungal Market Restraints in Global Market
Table 4. Key Players of Vaginal Antifungal in Global Market
Table 5. Top Vaginal Antifungal Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Vaginal Antifungal Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Vaginal Antifungal Revenue Share by Companies, 2019-2024
Table 8. Global Companies Vaginal Antifungal Product Type
Table 9. List of Global Tier 1 Vaginal Antifungal Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaginal Antifungal Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Vaginal Antifungal Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Vaginal Antifungal Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Vaginal Antifungal Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Vaginal Antifungal Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Vaginal Antifungal Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Vaginal Antifungal Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Vaginal Antifungal Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Vaginal Antifungal Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Vaginal Antifungal Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Vaginal Antifungal Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Vaginal Antifungal Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Vaginal Antifungal Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Vaginal Antifungal Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Vaginal Antifungal Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Vaginal Antifungal Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Vaginal Antifungal Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Vaginal Antifungal Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Vaginal Antifungal Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Vaginal Antifungal Revenue, (US$, Mn), 2025-2030
Table 30. ANI Pharmaceuticals Company Summary
Table 31. ANI Pharmaceuticals Vaginal Antifungal Product Offerings
Table 32. ANI Pharmaceuticals Vaginal Antifungal Revenue (US$, Mn) & (2019-2024)
Table 33. ANI Pharmaceuticals Key News & Latest Developments
Table 34. Lupin Company Summary
Table 35. Lupin Vaginal Antifungal Product Offerings
Table 36. Lupin Vaginal Antifungal Revenue (US$, Mn) & (2019-2024)
Table 37. Lupin Key News & Latest Developments
Table 38. Unique Pharmaceuticals Company Summary
Table 39. Unique Pharmaceuticals Vaginal Antifungal Product Offerings
Table 40. Unique Pharmaceuticals Vaginal Antifungal Revenue (US$, Mn) & (2019-2024)
Table 41. Unique Pharmaceuticals Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Vaginal Antifungal Product Offerings
Table 44. Pfizer Vaginal Antifungal Revenue (US$, Mn) & (2019-2024)
Table 45. Pfizer Key News & Latest Developments
Table 46. SCYNEXIS Company Summary
Table 47. SCYNEXIS Vaginal Antifungal Product Offerings
Table 48. SCYNEXIS Vaginal Antifungal Revenue (US$, Mn) & (2019-2024)
Table 49. SCYNEXIS Key News & Latest Developments
Table 50. Bausch Health Companies Company Summary
Table 51. Bausch Health Companies Vaginal Antifungal Product Offerings
Table 52. Bausch Health Companies Vaginal Antifungal Revenue (US$, Mn) & (2019-2024)
Table 53. Bausch Health Companies Key News & Latest Developments
Table 54. Hikma Pharmaceuticals Company Summary
Table 55. Hikma Pharmaceuticals Vaginal Antifungal Product Offerings
Table 56. Hikma Pharmaceuticals Vaginal Antifungal Revenue (US$, Mn) & (2019-2024)
Table 57. Hikma Pharmaceuticals Key News & Latest Developments
Table 58. Pacgen Life Science Corporation Company Summary
Table 59. Pacgen Life Science Corporation Vaginal Antifungal Product Offerings
Table 60. Pacgen Life Science Corporation Vaginal Antifungal Revenue (US$, Mn) & (2019-2024)
Table 61. Pacgen Life Science Corporation Key News & Latest Developments
Table 62. Astellas Pharma Company Summary
Table 63. Astellas Pharma Vaginal Antifungal Product Offerings
Table 64. Astellas Pharma Vaginal Antifungal Revenue (US$, Mn) & (2019-2024)
Table 65. Astellas Pharma Key News & Latest Developments
Table 66. Mycovia Pharmaceuticals Company Summary
Table 67. Mycovia Pharmaceuticals Vaginal Antifungal Product Offerings
Table 68. Mycovia Pharmaceuticals Vaginal Antifungal Revenue (US$, Mn) & (2019-2024)
Table 69. Mycovia Pharmaceuticals Key News & Latest Developments
Table 70. PEPTONIC Medical Company Summary
Table 71. PEPTONIC Medical Vaginal Antifungal Product Offerings
Table 72. PEPTONIC Medical Vaginal Antifungal Revenue (US$, Mn) & (2019-2024)
Table 73. PEPTONIC Medical Key News & Latest Developments
List of Figures
Figure 1. Vaginal Antifungal Segment by Type in 2023
Figure 2. Vaginal Antifungal Segment by Application in 2023
Figure 3. Global Vaginal Antifungal Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Vaginal Antifungal Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Vaginal Antifungal Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Vaginal Antifungal Revenue in 2023
Figure 8. By Type - Global Vaginal Antifungal Revenue Market Share, 2019-2030
Figure 9. By Application - Global Vaginal Antifungal Revenue Market Share, 2019-2030
Figure 10. By Type - Global Vaginal Antifungal Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Vaginal Antifungal Revenue Market Share, 2019-2030
Figure 12. By Application - Global Vaginal Antifungal Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Vaginal Antifungal Revenue Market Share, 2019-2030
Figure 14. By Region - Global Vaginal Antifungal Revenue Market Share, 2019-2030
Figure 15. By Country - North America Vaginal Antifungal Revenue Market Share, 2019-2030
Figure 16. US Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Vaginal Antifungal Revenue Market Share, 2019-2030
Figure 20. Germany Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 21. France Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Vaginal Antifungal Revenue Market Share, 2019-2030
Figure 28. China Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 32. India Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Vaginal Antifungal Revenue Market Share, 2019-2030
Figure 34. Brazil Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Vaginal Antifungal Revenue Market Share, 2019-2030
Figure 37. Turkey Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Vaginal Antifungal Revenue, (US$, Mn), 2019-2030
Figure 41. ANI Pharmaceuticals Vaginal Antifungal Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Lupin Vaginal Antifungal Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Unique Pharmaceuticals Vaginal Antifungal Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Pfizer Vaginal Antifungal Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. SCYNEXIS Vaginal Antifungal Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Bausch Health Companies Vaginal Antifungal Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Hikma Pharmaceuticals Vaginal Antifungal Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Pacgen Life Science Corporation Vaginal Antifungal Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Astellas Pharma Vaginal Antifungal Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Mycovia Pharmaceuticals Vaginal Antifungal Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. PEPTONIC Medical Vaginal Antifungal Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
